Standardization of In Vitro Testing During Development of Abuse-Deterrent Opioids: Highlights From the Second and Third Category 1 Focus Group Meetings

Affiliations

• ¹ Egalet US Inc, Wayne, Pennsylvania, U.S.A.
• ² Grünenthal GmbH, Aachen, Germany.
• ³ Baltimore School of Pharmacy, University of Maryland, Baltimore, Maryland, U.S.A.
• ⁴ Syneos Health, Raleigh, North Carolina, U.S.A.
• ⁵ Department of Toxicology and Pharmacology, University of Toronto, Toronto, Ontario, Canada.
• ⁶ Prescription Drug Research Center, Bradenton, Florida, U.S.A.
• ⁷ DrugScan, HorshamPennsylvania, U.S.A.
• ⁸ Vallon Pharmaceuticals, Inc, Philadelphia, Pennsylvania, U.S.A.